| |
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
The BioReliance Process Development group is able to provide a full program of process development services, creating a total, end-to-end solution.
Back to Process Development
BioReliance will optimize expression systems in bacterial, mammalian and insect cell lines for the production of recombinant proteins and monoclonal antibodies. We often take an existing R&D program and bring it to clinical trials by offering feasibility studies into scalable technologies for both the upstream and downstream portions of the program.
|
|
